Table: Immuno Biological Lab -2024/25 group results

Immuno-Biological Laboratories

14/05/2025 07:37

May 14 (Reuters)- 
          Immuno Biological Laboratories Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2025    Mar 31, 2024   Mar 31, 2026     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          969 mln         816 mln         1.03                  
               (+18.7 pct)     (+2.8 pct)     (+5.7 pct)               
  Operating      209 mln         104 mln        240 mln                
              (+100.7 pct)     (+82.5 pct)    (+14.6 pct)              
  Recurring      209 mln         125 mln        240 mln                
               (+67.3 pct)                    (+14.4 pct)              
  Net
  Net            249 mln         186 mln        265 mln                
               (+33.4 pct)                    (+6.4 pct)               
  EPS           26.74 yen       20.05 yen      28.45 yen               
  Ann Div          NIL             NIL         6.00 yen                
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div          NIL             NIL         6.00 yen                
  
  NOTE - Immuno Biological Laboratories Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T